These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23730692)

  • 21. Delivering silence: advancements in developing siRNA therapeutics.
    Novobrantseva TI; Akinc A; Borodovsky A; de Fougerolles A
    Curr Opin Drug Discov Devel; 2008 Mar; 11(2):217-24. PubMed ID: 18283609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Special issue of ChinaNanomedicine 2015.
    Shen Y
    Nanomedicine; 2016 Feb; 12(2):353. PubMed ID: 26711967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Focus on RNA interference: from nanoformulations to in vivo delivery.
    Karp JM; Peer D
    Nanotechnology; 2018 Jan; 29(1):010201. PubMed ID: 29185433
    [No Abstract]   [Full Text] [Related]  

  • 24. [Future prospects of RNA interference in cancer therapies].
    Ashihara E
    Rinsho Ketsueki; 2009 Oct; 50(10):1577-88. PubMed ID: 19915369
    [No Abstract]   [Full Text] [Related]  

  • 25. Self-assembled lipid nanomedicines for siRNA tumor targeting.
    Tseng YC; Huang L
    J Biomed Nanotechnol; 2009 Aug; 5(4):351-63. PubMed ID: 20055081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-homing poly-siRNA/glycol chitosan self-cross-linked nanoparticles for systemic siRNA delivery in cancer treatment.
    Lee SJ; Huh MS; Lee SY; Min S; Lee S; Koo H; Chu JU; Lee KE; Jeon H; Choi Y; Choi K; Byun Y; Jeong SY; Park K; Kim K; Kwon IC
    Angew Chem Int Ed Engl; 2012 Jul; 51(29):7203-7. PubMed ID: 22696263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
    Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X
    Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanomedicine and drug delivery.
    Wei C; Wei W; Morris M; Kondo E; Gorbounov M; Tomalia DA
    Med Clin North Am; 2007 Sep; 91(5):863-70. PubMed ID: 17826106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanomaterials for enhanced immunity as an innovative paradigm in nanomedicine.
    Seth A; Oh DB; Lim YT
    Nanomedicine (Lond); 2015; 10(6):959-75. PubMed ID: 25867860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SiRNA delivery: challenges and role of carrier systems.
    Shegokar R; Al Shaal L; Mishra PR
    Pharmazie; 2011 May; 66(5):313-8. PubMed ID: 21699063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging of siRNA delivery and silencing.
    Moore A; Medarova Z
    Methods Mol Biol; 2009; 487():93-110. PubMed ID: 19301644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Theranostic nanomedicine for cancer.
    Sumer B; Gao J
    Nanomedicine (Lond); 2008 Apr; 3(2):137-40. PubMed ID: 18373419
    [No Abstract]   [Full Text] [Related]  

  • 33. [Advance in the study of targeting delivery system for siRNA mediated by aptamers].
    Wang XL; Wang QQ; Song HF
    Yao Xue Xue Bao; 2012 Jul; 47(7):850-5. PubMed ID: 22993847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNA interference in vitro and in vivo using an arginine peptide/siRNA complex system.
    Kim SW; Kim NY; Choi YB; Park SH; Yang JM; Shin S
    J Control Release; 2010 May; 143(3):335-43. PubMed ID: 20079391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies.
    Vorhies JS; Nemunaitis J
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):373-82. PubMed ID: 17338656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review.
    Chaturvedi K; Ganguly K; Kulkarni AR; Kulkarni VH; Nadagouda MN; Rudzinski WE; Aminabhavi TM
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1455-68. PubMed ID: 21867463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging-guided revival of nanomedicine?
    Senders ML; Fayad ZA; Reiner T; Mulder WJ; Pérez-Medina C
    Nanomedicine (Lond); 2017 Jan; 12(2):89-90. PubMed ID: 27876441
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibacterial nanomedicine.
    Yacoby I; Benhar I
    Nanomedicine (Lond); 2008 Jun; 3(3):329-41. PubMed ID: 18510428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel nanosome delivery system combined with siRNA targeting the antimicrobial gene DFB4: a new approach for psoriasis management?
    Keren A; David M; Gilhar A
    Exp Dermatol; 2014 Jul; 23(7):464-5. PubMed ID: 24673207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioengineering nanotechnology: towards the clinic.
    Zhao W; Karp JM; Ferrari M; Serda R
    Nanotechnology; 2011 Dec; 22(49):490201. PubMed ID: 22101146
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.